KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Opko Health (OPK) Capital Expenditures (2016 - 2026)

Opko Health filings provide 17 years of Capital Expenditures readings, the most recent being $1.8 million for Q1 2026.

On a quarterly basis, Capital Expenditures fell 42.61% to $1.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.9 million, a 71.93% decrease, with the full-year FY2025 number at $12.3 million, down 50.91% from a year prior.
Capital Expenditures hit $1.8 million in Q1 2026 for Opko Health, down from $2.7 million in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $19.6 million in Q3 2024 to a low of $1.8 million in Q1 2026.
Median Capital Expenditures over the past 5 years was $4.3 million (2023), compared with a mean of $5.7 million.
Biggest five-year swings in Capital Expenditures: skyrocketed 366.26% in 2024 and later crashed 84.0% in 2025.
Opko Health's Capital Expenditures stood at $6.3 million in 2022, then tumbled by 52.3% to $3.0 million in 2023, then surged by 548.48% to $19.6 million in 2024, then tumbled by 86.4% to $2.7 million in 2025, then crashed by 31.25% to $1.8 million in 2026.
The last three reported values for Capital Expenditures were $1.8 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025) per Business Quant data.